Skip to main content

Table 4 Clinical characteristics and outcomes in intervention group and control group patients after 6 months

From: Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

  Intervention group Control group T-value Sig.
Mean (S.D.) Mean (S.D.)
General overuse 11.93 (2.15) 12.63 (2.61) 2.197 0.029a
General harm 10.08 (2.25) 10.67 (2.90) 1.687 0.093
Beneficial effect of pharmaceuticals 15.35 (2.04) 15.25 (2.15) 0.356 0.722
Beliefs about medicines 35.36 (3.62) 38.12 (4.43) 5.055 <0.0001a
Sensitive 15.10 (2.56) 15.39 (3.10) 0.769 0.442
Necessity beliefs 19.00 (3.83) 18.50 (4.19) 0.939 0.349
Concern beliefs 12.05 (3.08) 13.14 (3.97) 2.278 0.024
Treatment Satisfaction Questionnaire for Medication (TSQM) 88.71 (10.77) 82.89 (13.40) 3.551 <0.0001a
Estimated weights for EQ-5D 0.68 (0.40) 0.66 (0.38) 0.356 0.722
Montgomery–Åsberg Depression Scale 20.65 (11.97) 20.86 (12.54) 0.129 0.897
Medication Adherence Scale 5.99 (1.88) 4.94 (1.94) 4.059 <0.0001a
  1. aSignificantly different